4.5 Article

CUX1-related neurodevelopmental disorder: deep insights into phenotype-genotype spectrum and underlying pathology

期刊

出版社

SPRINGERNATURE
DOI: 10.1038/s41431-023-01445-2

关键词

-

向作者/读者索取更多资源

This study describes the clinical presentation in an extended cohort and investigates the molecular mechanism in a Cux1(+/-) mouse model. Disease-causing CUX1 variants result in a non-syndromic phenotype of developmental delay and intellectual disability. In some individuals, this phenotype improves with age, resulting in a clinical catch-up and normal IQ in adulthood.
Heterozygous, pathogenic CUX1 variants are associated with global developmental delay or intellectual disability. This study delineates the clinical presentation in an extended cohort and investigates the molecular mechanism underlying the disorder in a Cux1(+/-) mouse model. Through international collaboration, we assembled the phenotypic and molecular information for 34 individuals (23 unpublished individuals). We analyze brain CUX1 expression and susceptibility to epilepsy in Cux1(+/-) mice. We describe 34 individuals, from which 30 were unrelated, with 26 different null and four missense variants. The leading symptoms were mild to moderate delayed speech and motor development and borderline to moderate intellectual disability. Additional symptoms were muscular hypotonia, seizures, joint laxity, and abnormalities of the forehead. In Cux1(+/-) mice, we found delayed growth, histologically normal brains, and increased susceptibility to seizures. In Cux1(+/-) brains, the expression of Cux1 transcripts was half of WT animals. Expression of CUX1 proteins was reduced, although in early postnatal animals significantly more than in adults. In summary, disease-causing CUX1 variants result in a non-syndromic phenotype of developmental delay and intellectual disability. In some individuals, this phenotype ameliorates with age, resulting in a clinical catch-up and normal IQ in adulthood. The post-transcriptional balance of CUX1 expression in the heterozygous brain at late developmental stages appears important for this favorable clinical course.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Preimplantation genetic testing in two Danish couples affected by Peutz-Jeghers syndrome

Anna Byrjalsen, Laura Roos, Tue Diemer, John Gasdal Karstensen, Kristine Lossl, Anne Marie Jelsig

Summary: PGT-M can be offered to patients with PJS, but the process can be challenging and requires motivation and persistence from patients.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Genetics & Heredity

SCIP: software for efficient clinical interpretation of copy number variants detected by whole-genome sequencing

Qiliang Ding, Cherith Somerville, Roozbeh Manshaei, Brett Trost, Miriam S. Reuter, Kelsey Kalbfleisch, Kaitlin Stanley, John B. A. Okello, S. Mohsen Hosseini, Eriskay Liston, Meredith Curtis, Mehdi Zarrei, Edward J. Higginbotham, Ada J. S. Chan, Worrawat Engchuan, Bhooma Thiruvahindrapuram, Stephen W. Scherer, Raymond H. Kim, Rebekah K. Jobling

Summary: This study introduces SCIP, a software package that enables efficient and accurate clinical interpretation of CNVs, facilitating improved genetic diagnoses.

HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome

Zain Awamleh, Sanaa Choufani, Cheryl Cytrynbaum, Fowzan S. Alkuraya, Stephen Scherer, Sofia Fernandes, Catarina Rosas, Pedro Louro, Patricia Dias, Mariana Tomasio Neves, Sergio B. Sousa, Rosanna Weksberg

Summary: Pathogenic variants in ANKRD11 or microdeletions at 16q24.3 cause KBG syndrome and are associated with unique DNAm signatures. These DNAm profiles can be used for diagnostic purposes and can help classify individuals with variants of uncertain significance in ANKRD11.

HUMAN MOLECULAR GENETICS (2023)

Article Biochemistry & Molecular Biology

Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome

Brianna K. Unda, Leon Chalil, Sehyoun Yoon, Savannah Kilpatrick, Courtney Irwin, Sansi Xing, Nadeem Murtaza, Anran Cheng, Chad Brown, Alexandria Afonso, Elizabeth McCready, Gabriel M. Ronen, Jennifer Howe, Aurelie Caye-Eude, Alain Verloes, Brad W. Doble, Laurence Faivre, Antonio Vitobello, Stephen W. Scherer, Yu Lu, Peter Penzes, Karun K. Singh

Summary: Copy number variations (CNVs) are associated with psychiatric and neurodevelopmental disorders (NDDs), and the underlying disease mechanisms for most CNVs are unknown. In this study, a 15q13.3 microdeletion mouse model and patient iPSC-derived neurons were used to investigate the developmental defects caused by the CNV. By targeting the 15q13.3 CNV genetic driver OTUD7A, the study revealed a critical OTUD7A-Ankyrin pathway in neuronal development and dysfunction in the 15q13.3 microdeletion syndrome.

MOLECULAR PSYCHIATRY (2023)

Article Oncology

The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations

Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W. W. Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D. D. Anderson, Arun K. K. Ramani, Kyoko E. E. Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D. D. Wasserman, Rosemarie E. E. Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan A. Han, Maria Montero, Famida Spatare, James A. A. Whitlock, Stephen W. W. Scherer, Kathy Chun, Martin J. J. Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramaswamy, Gino R. R. Somers, Lianna Kyriakopoulou, Johann Hitzler, Mary Shago, Daniel A. A. Morgenstern, Uri Tabori, Stephen Meyn, Meredith S. S. Irwin, David Malkin, Adam Shlien

Summary: We conducted integrative somatic-germline analyses on 300 cancer patients, sequencing 864 cancer-associated genes, complete genomes, and transcriptomes. Clinically actionable variants were found in 56% of patients, leading to modified management in some cases. Therapeutically targetable variants, derived from both somatic and germline sources, were present in 54% of patients.

NATURE CANCER (2023)

Article Oncology

Whole genome sequencing and disease pattern in patients with juvenile polyposis syndrome: a nationwide study

Anne Marie Jelsig, Thomas van Overeem Hansen, Lene Bjerring Gede, Niels Qvist, Lise-Lotte Christensen, Charlotte Kvist Lautrup, Ken Ljungmann, Louise Torp Christensen, Karina Ronlund, Pernille Mathiesen Torring, Birgitte Bertelsen, Lone Sunde, John Gasdal Karstensen

Summary: Juvenile polyposis syndrome (JPS) is a hereditary syndrome characterized by gastrointestinal juvenile polyps and increased risk of gastrointestinal cancer. Genetic analysis was performed on Danish patients with a clinical diagnosis of JPS or pathogenic variants in BMPR1A or SMAD4. The study revealed that the majority of JPS patients have pathogenic variants in BMPR1A, SMAD4, or PTEN, and not all patients with a pathogenic variant fulfill the clinical criteria of JPS. The study also demonstrated a wide clinical spectrum and variability in the histopathology of removed polyps.

FAMILIAL CANCER (2023)

Article Genetics & Heredity

Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family

Paola Concolino, Elisa De Paolis, Simona Moffa, Maria Elisabetta Onori, Laura Soldovieri, Claudio Ricciardi Tenore, Maria De Bonis, Claudio Rabacchi, Concetta Santonocito, Martina Rinelli, Sebastiano Calandra, Andrea Giaccari, Andrea Urbani, Angelo Minucci

Summary: Next-generation sequencing (NGS) is commonly used for clinical purposes and can effectively identify copy number variations (CNVs) and small-scale alterations in FH-related genes. In an Italian family, a novel large deletion in the LDLR gene involving exons 4-18 was identified through bioinformatic analysis of NGS data. The use of NGS as a cost-effective and efficient molecular approach meets the clinical need for personalized diagnosis in FH cases.
Article Genetics & Heredity

HostSeq: a Canadian whole genome sequencing and clinical data resource

S. Yoo, E. Garg, L. T. Elliott, R. J. Hung, A. R. Halevy, J. D. Brooks, S. B. Bull, F. Gagnon, C. M. T. Greenwood, J. F. Lawless, A. D. Paterson, L. Sun, M. H. Zawati, J. Lerner-Ellis, R. J. S. Abraham, I Birol, G. Bourque, J-m Garant, C. Gosselin, J. Li, J. Whitney, B. Thiruvahindrapuram, J-a Herbrick, M. Lorenti, M. S. Reuter, O. O. Adeoye, S. Liu, U. Allen, F. P. Bernier, C. M. Biggs, A. M. Cheung, J. Cowan, M. Herridge, D. M. Maslove, B. P. Modi, V Mooser, S. K. Morris, M. Ostrowski, R. S. Parekh, G. Pfeffer, O. Suchowersky, J. Taher, J. Upton, R. L. Warren, R. S. M. Yeung, N. Aziz, S. E. Turvey, B. M. Knoppers, M. Lathrop, S. J. M. Jones, S. W. Scherer, L. J. Strug

Summary: HostSeq was launched in April 2020 to integrate whole genome sequencing data and clinical information of 10,000 Canadians infected with SARS-CoV-2. It aims to support research communities in understanding disease risk factors and developing interventions. HostSeq is a collaboration among 13 epidemiological studies across five provinces in Canada, providing aggregated data through two portals and individual-level data for global health research.

BMC GENOMIC DATA (2023)

Article Behavioral Sciences

Linkage of whole genome sequencing and administrative health data in autism: A proof of concept study

Danielle A. Baribeau, Jasleen Arneja, Xuesong Wang, Jennifer Howe, John R. McLaughlin, Karen Tu, Jun Guan, Alana Iaboni, Elizabeth Kelley, Muhammad Ayub, Robert Nicolson, Stelios Georgiades, Stephen W. Scherer, Susan E. Bronskill, Evdokia Anagnostou, Jennifer D. Brooks

Summary: This study aimed to determine whether carrying an autism-associated rare genetic variant is associated with differences in health system utilization by autistic children and youth. The study found that participants with a rare variant impacting an autism-associated gene were less likely to have received psychiatric care, but there were no differences in health care costs and the proportion with complex chronic medical conditions.

AUTISM RESEARCH (2023)

Article Clinical Neurology

Natural History and Developmental Trajectories of Individuals With Disease-Causing Variants in STXBP1

Kim M. Thalwitzer, Jan H. Driedger, Julie Xian, Afshin Saffari, Pia Zacher, Bigna K. Boelsterli, Sarah McKeown Ruggiero, Katie Rose Sullivan, Alexandre N. Datta, Christoph Kellinghaus, Juergen Althaus, Adelheid Wiemer-Kruel, Andreas van Baalen, Armin Pampel, Michael Alber, Hilde M. H. Braakman, Otfried M. Debus, Jonas Denecke, Elke Hobbiebrunken, Ina Breitweg, Danielle Diehl, Hans Eitel, Janina Gburek-Augustat, Martin Preisel, Jan-Ulrich Schlump, Mirjam Laufs, Dilbar Mammadova, Carsten Wurst, Christine Prager, Christa Loehr-Nilles, Peter Martin, Sven F. Garbade, Konrad Platzer, Ira Benkel-Herrenbrueck, Kerstin Egler, Walid Fazeli, Johannes R. Lemke, Eva Runkel, Barbara Klein, Tobias Linden, Julian Schroeter, Heike Steffeck, Bastian Thies, Florian von Deimling, Sabine Illsinger, Ingo Borggraefe, Georg Classen, Dagmar Wieczorek, Georgia Ramantani, Stefan Koelker, Georg F. Hoffmann, Markus Ries, Ingo Helbig, Steffen Syrbe

Summary: This study provides insights into the clinical features and developmental trajectories of individuals with STXBP1-related disorders, with and without a history of epilepsy. Individuals with epilepsy, particularly epileptic spasms, and neonatal or early-onset presented with less favorable motor and language functional outcomes compared with individuals without epilepsy. These findings can identify children at risk for severe disease and serve as a comparator for future interventional studies in STXBP1-related disorders.

NEUROLOGY (2023)

Article Genetics & Heredity

Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study

Mona Abdi, Elbay Aliyev, Brett Trost, Muhammad Kohailan, Waleed Aamer, Najeeb Syed, Rulan Shaath, Geethanjali Devadoss Gandhi, Worrawat Engchuan, Jennifer Howe, Bhooma Thiruvahindrapuram, Melissa Geng, Joe Whitney, Amira Syed, Jyothi Lakshmi, Sura Hussein, Najwa Albashir, Amal Hussein, Ilaria Poggiolini, Saba F. Elhag, Sasirekha Palaniswamy, Marios Kambouris, Maria de Fatima Janjua, Mohamed O. El Tahir, Ahsan Nazeer, Durre Shahwar, Muhammad Waqar Azeem, Younes Mokrab, Nazim Abdel Aati, Ammira Akil, Stephen W. Scherer, Madeeha Kamal, Khalid A. Fakhro

Summary: This study identified potentially pathogenic variants in ASD families in Qatar, with a significant proportion being single-gene variants. It also highlighted the impact of recessive variation on the ASD architecture in consanguineous settings, providing a unique genomic resource for future ASD research in the global community.

GENOME MEDICINE (2023)

Article Genetics & Heredity

I don't need any more unknowns hanging over my head: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing

Salma Shickh, Chloe Mighton, Marc Clausen, Rita Kodida, Ella Adi-Wauran, Daena Hirjikaka, Suvetha Krishnapillai, Emma Reble, Jordan Sam, Nancy N. Baxter, Andreas Laupacis, Yvonne Bombard

Summary: This study aims to explore the patient-reported utility of cancer results from genomic sequencing (GS). Results showed that patients' perceptions of the utility of GS results were dependent on whether they triggered clinical action. Patients who received results without clinical action became hypervigilant and experienced negative effects. Therefore, there is a need to develop practice interventions to support cancer patients undergoing GS.

GENETICS IN MEDICINE (2023)

暂无数据